All Episodes

July 15, 2025 58 mins

Send us a text

Disclaimer: Causes or Cures is for informational purposes only. It is not medical advice, and no medical claims are being made. Always talk to a qualified healthcare provider about your personal health. 

In this episode of Causes or Cures, Dr. Eeks chats with immunology expert Dr. Maziar “Maz” Divangahi about his research on how fiber found in mushrooms may help us beat the flu, and he introduces us to the concept of disease tolerance. 

What We’ll Cover

  1. Beta-Glucan 101
    • What it is: a natural fiber in the outer wall of fungi (think mushrooms).
    • Why it matters: growing evidence says it may help fight off the flu by improving something called disease tolerance. More research is needed to confirm. 
  2. Two Immune Playbooks
    • Host Resistance: the classic “seek and destroy” tactic.
    • Disease Tolerance: a quieter, damage-control strategy our bodies use to stay functional even when a pathogen sticks around.
    • Dr. Maz will unpack how beta-glucan may tilt the balance toward disease tolerance.
  3. From TB Labs to Flu Research
    • Insights from Dr. Maz’s tuberculosis studies that set the stage for his beta-glucan–flu work.
    • Early data on how this fungal fiber might boost flu-specific disease tolerance.
  4. Should We Eat More Mushrooms or Supplement?
    • Practical tips and caveats on dietary vs. supplemental beta-glucan.
    • What the current evidence actually supports.
  5. Beyond Infections: Beta-Glucan in Cancer Trials
    • Snapshot of ongoing studies in breast and bladder cancer.
    • Why disease tolerance is a hot oncology frontier.
  6. Future Directions & Take-Home Points
    • Where Dr. Maz’s research is headed next.
    • Simple, science-backed actions listeners can try today.

Listen If You’ve Ever Wondered…

  • Why some people sail through the flu while others end up in the ER.
  • Whether “disease tolerance” might rewrite how we tackle pandemics.
  • If tossing extra shiitakes into your stir-fry can really make a difference.

Dr. Maziar (Maz) Divangahi is a Professor of Medicine at McGill University. He is the Associate Director of the Meakins-Christie Laboratories and the Associate Director of the McGill Interna onal TB Centre. He is an internationally recognized pulmonary immunologist and the overarching focus of his research program is to inves gate the regulatory mechanisms involved in host resistance and disease tolerance against major pulmonary bacterial (Mycobacterium tuberculosis) and viral (influenza virus and SARS-CoV2) pathogens. He is currently inves ga ng how to harness the power of innate memory response (Trained Immunity) in vaccine development. Throughout his career, he has been a prolifera ve inves gator publishing in outstanding journals and received numerous awards, including a CIHR New Inves gator Award, FRQS Award, and the CIHR Founda on grant. His scholarly work has been recognized by elec on to the Royal Society of Canada. He is currently holding the Strauss Chair in Respiratory Diseases. 

You can contact Dr. Eeks at bloomingwellness.com.
Follow Eeks on Instagram here.
Or Facebook here.
Or X.
On Youtube

Support the show

Mark as Played

Advertise With Us

Popular Podcasts

On Purpose with Jay Shetty

On Purpose with Jay Shetty

I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!

Ruthie's Table 4

Ruthie's Table 4

For more than 30 years The River Cafe in London, has been the home-from-home of artists, architects, designers, actors, collectors, writers, activists, and politicians. Michael Caine, Glenn Close, JJ Abrams, Steve McQueen, Victoria and David Beckham, and Lily Allen, are just some of the people who love to call The River Cafe home. On River Cafe Table 4, Rogers sits down with her customers—who have become friends—to talk about food memories. Table 4 explores how food impacts every aspect of our lives. “Foods is politics, food is cultural, food is how you express love, food is about your heritage, it defines who you and who you want to be,” says Rogers. Each week, Rogers invites her guest to reminisce about family suppers and first dates, what they cook, how they eat when performing, the restaurants they choose, and what food they seek when they need comfort. And to punctuate each episode of Table 4, guests such as Ralph Fiennes, Emily Blunt, and Alfonso Cuarón, read their favourite recipe from one of the best-selling River Cafe cookbooks. Table 4 itself, is situated near The River Cafe’s open kitchen, close to the bright pink wood-fired oven and next to the glossy yellow pass, where Ruthie oversees the restaurant. You are invited to take a seat at this intimate table and join the conversation. For more information, recipes, and ingredients, go to https://shoptherivercafe.co.uk/ Web: https://rivercafe.co.uk/ Instagram: www.instagram.com/therivercafelondon/ Facebook: https://en-gb.facebook.com/therivercafelondon/ For more podcasts from iHeartRadio, visit the iheartradio app, apple podcasts, or wherever you listen to your favorite shows. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.